Asunto(s)
Descubrimiento de Drogas , Genoma Humano , ARN no Traducido/genética , Secuencias Reguladoras de Ácidos Nucleicos/genética , Cromatina/química , Cromatina/genética , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Mutación , ARN no Traducido/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacosRESUMEN
Renin, encoded by REN, is an essential enzyme in the renin-angiotensin aldosterone system (RAAS) which is responsible for the maintenance of blood pressure homeostasis. Transcriptional regulation of REN has been linked to enhancer-promoter crosstalk, cAMP response element-binding protein (CREB), the active metabolite of vitamin D, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), and a less well-characterized intronic silencer element. We hypothesized that in addition to these, differential DNA methylation is linked to REN expression and influenced by 1,25(OH)2D3. REN expressing cells (HEK293) were used to elucidate the effect of 1,25(OH)2D3 on REN methylation and expression as quantified by methylation-sensitive qPCR and RT-qPCR, respectively. In vitro 1,25(OH)2D3 supplementation (10 nM) induced significant hypomethylation of the REN silencer (P < 0.050), which was linked to a significant reduction in REN expression (P < 0.010) but had no effect on enhancer methylation. In addition, 1,25(OH)2D3 increased VDR (P < 0.05), as well as TET1 (P < 0.05) expression, suggesting an association between 1,25(OH)2D3 and DNA methylation. Thus, it appears that the silencer element, which is controlled by DNA methylation and influenced by 1,25(OH)2D3, plays an essential role in regulating REN expression.
Asunto(s)
Metilación de ADN/efectos de los fármacos , Oxigenasas de Función Mixta/genética , Proteínas Proto-Oncogénicas/genética , Receptores de Calcitriol/genética , Renina/genética , Vitamina D/farmacología , Regulación hacia Abajo , Epigénesis Genética/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Células HEK293 , Humanos , Regiones Promotoras Genéticas/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacosRESUMEN
BACKGROUND: Cigarette smoke is a causal factor in cancers and cardiovascular disease. Smoking-associated differentially methylated regions (SM-DMRs) have been observed in disease studies, but the causal link between altered DNA methylation and transcriptional change is obscure. OBJECTIVE: Our objectives were to finely resolve SM-DMRs and to interrogate the mechanistic link between SM-DMRs and altered transcription of enhancer noncoding RNA (eRNA) and mRNA in human circulating monocytes. METHOD: We integrated SM-DMRs identified by reduced representation bisulfite sequencing (RRBS) of circulating CD14+ monocyte DNA collected from two independent human studies [n=38 from Clinical Research Unit (CRU) and n=55 from the Multi-Ethnic Study of Atherosclerosis (MESA), about half of whom were active smokers] with gene expression for protein-coding genes and noncoding RNAs measured by RT-PCR or RNA sequencing. Candidate SM-DMRs were compared with RRBS of purified CD4+ T cells, CD8+ T cells, CD15+ granulocytes, CD19+ B cells, and CD56+ NK cells (n=19 females, CRU). DMRs were validated using pyrosequencing or bisulfite amplicon sequencing in up to 85 CRU volunteers, who also provided saliva DNA. RESULTS: RRBS identified monocyte SM-DMRs frequently located in putative gene regulatory regions. The most significant monocyte DMR occurred at a poised enhancer in the aryl-hydrocarbon receptor repressor gene (AHRR) and it was also detected in both granulocytes and saliva DNA. To our knowledge, we identify for the first time that SM-DMRs in or near AHRR, C5orf55-EXOC-AS, and SASH1 were associated with increased noncoding eRNA as well as mRNA in monocytes. Functionally, the AHRR SM-DMR appeared to up-regulate AHRR mRNA through activating the AHRR enhancer, as suggested by increased eRNA in the monocytes, but not granulocytes, from smokers compared with nonsmokers. CONCLUSIONS: Our findings suggest that AHRR SM-DMR up-regulates AHRR mRNA in a monocyte-specific manner by activating the AHRR enhancer. Cell type-specific activation of enhancers at SM-DMRs may represent a mechanism driving smoking-related disease. https://doi.org/10.1289/EHP2395.
Asunto(s)
Metilación de ADN/efectos de los fármacos , ARN Mensajero/efectos de los fármacos , ARN no Traducido/efectos de los fármacos , Fumar/efectos adversos , Sulfitos/efectos adversos , Transcripción Genética/efectos de los fármacos , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , ARN Mensajero/metabolismo , ARN no Traducido/metabolismo , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/genéticaRESUMEN
Recently, we reported the unexpected finding that the monoubiquitination of histone H2B (H2Bub1) regulates inducible enhancers. Here, we propose a conceptual framework to reconcile the apparently discrepant roles of H2Bub1 in transcription initiation and elongation, and we discuss how H2Bub1 could regulate cellular processes linked to non-coding transcription.
Asunto(s)
Histonas/metabolismo , Secuencias Reguladoras de Ácidos Nucleicos , Animales , Metilación de ADN , Estradiol/farmacología , Receptor alfa de Estrógeno/metabolismo , Histonas/genética , Humanos , Células MCF-7 , FN-kappa B/metabolismo , ARN/biosíntesis , ARN Polimerasa II/metabolismo , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Elongación de la Transcripción Genética , Iniciación de la Transcripción Genética , Ubiquitinación/efectos de los fármacosRESUMEN
Nucleotide changes in gene regulatory elements can have a major effect on interindividual differences in drug response. For example, by reviewing all published pharmacogenomic genome-wide association studies, we show here that 96.4% of the associated single nucleotide polymorphisms reside in noncoding regions. We discuss how sequencing technologies are improving our ability to identify drug response-associated regulatory elements genome-wide and to annotate nucleotide variants within them. We highlight specific examples of how nucleotide changes in these elements can affect drug response and illustrate the techniques used to find them and functionally characterize them. Finally, we also discuss challenges in the field of drug-responsive regulatory elements that need to be considered in order to translate these findings into the clinic.
Asunto(s)
Preparaciones Farmacéuticas/administración & dosificación , Elementos Reguladores de la Transcripción/efectos de los fármacos , Elementos Reguladores de la Transcripción/genética , Animales , Genoma Humano/efectos de los fármacos , Genoma Humano/genética , Estudio de Asociación del Genoma Completo/tendencias , Humanos , Polimorfismo de Nucleótido Simple/efectos de los fármacos , Polimorfismo de Nucleótido Simple/genética , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/genéticaRESUMEN
BACKGROUND: Cadmium (Cd) is a ubiquitous and environmentally persistent toxic metal that has been implicated in neurotoxicity, carcinogenesis and obesity and essential metals including zinc (Zn) and iron (Fe) may alter these outcomes. However mechanisms underlying these relationships remain limited. METHODS: We examined whether maternal Cd levels during early pregnancy were associated with offspring DNA methylation at regulatory sequences of genomically imprinted genes and weight at birth, and whether Fe and Zn altered these associations. Cd, Fe and Zn were measured in maternal blood of 319 women ≤ 12 weeks gestation. Offspring umbilical cord blood leukocyte DNA methylation at regulatory differentially methylated regions (DMRs) of 8 imprinted genes was measured using bisulfite pyrosequencing. Regression models were used to examine the relationships among Cd, Fe, Zn, and DMR methylation and birth weight. RESULTS: Elevated maternal blood Cd levels were associated with lower birth weight (p = 0.03). Higher maternal blood Cd levels were also associated with lower offspring methylation at the PEG3 DMR in females (ß = 0.55, se = 0.17, p = 0.05), and at the MEG3 DMR in males (ß = 0.72, se = 0.3, p = 0.08), however the latter association was not statistically significant. Associations between Cd and PEG3 and PLAGL1 DNA methylation were stronger in infants born to women with low concentrations of Fe (p < 0.05). CONCLUSIONS: Our data suggest the association between pre-natal Cd and offspring DNA methylation at regulatory sequences of imprinted genes may be sex- and gene-specific. Essential metals such as Zn may mitigate DNA methylation response to Cd exposure. Larger studies are required.
Asunto(s)
Peso al Nacer/efectos de los fármacos , Cadmio/toxicidad , Metilación de ADN/efectos de los fármacos , Sangre Fetal/metabolismo , Hierro/farmacología , Exposición Materna/efectos adversos , Zinc/farmacología , Adulto , Cadmio/sangre , Metilación de ADN/genética , Interacciones Farmacológicas , Femenino , Ácido Fólico/sangre , Humanos , Lactante , Hierro/sangre , Masculino , Embarazo , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Adulto Joven , Zinc/sangreRESUMEN
How polyphagous herbivores up-regulate their counterdefense genes in response to a broad range of structurally different allelochemicals remains largely unknown. To test whether this is accomplished by having more allelochemical-response elements or the similar number of functionally more diverse elements, we mapped out the cis-acting elements mediating the induction of the allelochemical-metabolizing CYP321A1 from the generalist Helicoverpa zea by xanthotoxin and flavone, two structurally distinct allelochemicals with very different encounter rate by this species. Seven xanthotoxin-responsive elements were localized by analyzing promoter activities of varying length of CYP321A1 promoter in H. zea fatbody cells. Compared with the 5 flavone-responsive elements mapped out previously, there are four common elements (1 essential element, 2 enhancers, and 1 negative element) mediating induction of CYP321A1 by both of the two allelochemicals. The remaining four elements (3 enhancers and 1 negative element), however, only regulate induction of CYP321A1 by either of the two allelochemicals. Co-administration of the two allelochemicals resulted in an induction fold that is significantly lower than the expected additive value of the two allelochemicals. These results indicate that xanthotoxin- and flavone-induced expressions of CYP321A1 are mediated mainly by the functionally more diverse common elements although the allelochemical-unique elements also play a role.
Asunto(s)
Sistema Enzimático del Citocromo P-450/genética , Flavonas/farmacología , Lepidópteros/enzimología , Metoxaleno/farmacología , Secuencia de Aminoácidos/genética , Animales , Sistema Enzimático del Citocromo P-450/biosíntesis , Regulación de la Expresión Génica/efectos de los fármacos , Insecticidas/administración & dosificación , Insecticidas/farmacología , Lepidópteros/efectos de los fármacos , Regiones Promotoras Genéticas/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/genéticaRESUMEN
Mitochondria are crucial players in the signaling and metabolic homeostasis of the plant cell. The molecular components that orchestrate the underlying processes, however, are largely unknown. Using a chemical biology approach, we exploited the responsiveness of Arabidopsis UDP-glucosyltransferase-encoding UGT74E2 towards mitochondrial perturbation in order to look for novel mechanisms regulating mitochondria-to-nucleus communication. The most potent inducers of UGT74E2 shared a (2-furyl)acrylate (FAA) substructure that negatively affected mitochondrial function and was identified before as an auxin transcriptional inhibitor. Based on these premises, we demonstrated that perturbed mitochondria negatively affect the auxin signaling machinery. Moreover, chemical perturbation of polar auxin transport and auxin biosynthesis was sufficient to induce mitochondrial retrograde markers and their transcript abundance was constitutively elevated in the absence of the auxin transcriptional activators ARF7 and ARF19.
Asunto(s)
Ácidos Indolacéticos/metabolismo , Mitocondrias/metabolismo , Transducción de Señal , Acrilatos/farmacología , Arabidopsis/citología , Arabidopsis/efectos de los fármacos , Arabidopsis/genética , Proteínas de Arabidopsis/genética , Mitocondrias/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/genética , Transducción de Señal/efectos de los fármacosRESUMEN
Changes in organellar gene expression (OGE) trigger retrograde signaling. The molecular dissection of OGE-dependent retrograde signaling based on analyses of mutants with altered OGE is complicated by compensatory responses that mask the primary signaling defect and by secondary effects that influence other retrograde signaling pathways. Therefore, to identify the earliest effects of altered OGE on nuclear transcript accumulation, we have induced OGE defects in adult plants by ethanol-dependent repression of PRORS1, which encodes a prolyl-tRNA synthetase located in chloroplasts and mitochondria. After 32h of PRORS1 repression, the translational capacity of chloroplasts was reduced, and this effect subsequently intensified, while basic photosynthetic parameters were still unchanged at 51h. Analysis of changes in whole-genome transcriptomes during exposure to ethanol revealed that induced PRORS1 silencing affects the expression of 1020 genes in all. Some of these encode photosynthesis-related proteins, including several down-regulated light-harvesting chlorophyll a/b binding (LHC) proteins. Interestingly, genes for presumptive endoplasmic reticulum proteins are transiently up-regulated. Furthermore, several NAC-domain-containing proteins are among the transcription factors regulated. Candidate cis-acting elements which may coordinate the transcriptional co-regulation of genes sets include both G-box variants and sequence motifs with no similarity to known plant cis-elements.
Asunto(s)
Proteínas de Arabidopsis/metabolismo , Arabidopsis/citología , Arabidopsis/genética , Biosíntesis de Proteínas , Transducción de Señal , Factores de Transcripción/metabolismo , Aminoacil-ARNt Sintetasas/deficiencia , Aminoacil-ARNt Sintetasas/genética , Arabidopsis/efectos de los fármacos , Proteínas de Arabidopsis/genética , Regulación hacia Abajo/efectos de los fármacos , Etanol/farmacología , Perfilación de la Expresión Génica , Silenciador del Gen/efectos de los fármacos , Fotosíntesis/efectos de los fármacos , Plastidios/efectos de los fármacos , Plastidios/metabolismo , Biosíntesis de Proteínas/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/genética , Transducción de Señal/efectos de los fármacosRESUMEN
AIM: To evaluate the in vitro effect of amoxicillin and clarithromycin on the cag pathogenicity island (cag PAI). METHODS: One hundred and forty-nine clinical isolates of Helicobacter pylori (H. pylori) cultured from gastric biopsies from 206 Colombian patients with dyspeptic symptoms from a high-risk area for gastric cancer were included as study material. Antimicrobial susceptibility was determined by the agar dilution method. Resistant isolates at baseline and in amoxicillin and clarithromycin serial dilutions were subjected to genotyping (cagA, vacA alleles s and m), Glu-Pro-Ile-Tyr-Ala (EPIYA) polymerase chain reaction and random amplified polymorphic DNA (RAPD). Images of the RAPD amplicons were analyzed by Gel-Pro Analyzer 4.5 program. Cluster analyses was done using SPSS 15.0 statistical package, where each of the fingerprint bands were denoted as variables. Dendrograms were designed by following Ward's clustering method and the estimation of distances between each pair of H. pylori isolates was calculated with the squared Euclidean distance. RESULTS: Resistance rates were 4% for amoxicillin and 2.7% for clarithromycin with 2% double resistances. Genotyping evidenced a high prevalence of the genotype cagA-positive/vacA s1m1. The 3' region of cagA gene was successfully amplified in 92.3% (12/13) of the baseline resistant isolates and in 60% (36/60) of the resistant isolates growing in antibiotic dilutions. Upon observing the distribution of the number of EPIYA repetitions in each dilution with respect to baseline isolates, it was found that in 61.5% (8/13) of the baseline isolates, a change in the number of EPIYA repetitions lowered antibiotic pressure. The gain and loss of EPIYA motifs resulted in a diversity of H. pylori subclones after bacterial adjustment to changing conditions product of antibiotic pressure. RAPD PCR evidenced the close clonal relationship between baseline isolates and isolates growing in antibiotic dilutions. CONCLUSION: Antibiotic pressure does not induce loss of the cag pathogenicity island, but it can lead--in most cases--to genetic rearrangements within the 3' region cagA of the founding bacteria that can affect the level of tyrosine phosphorylation impacting on its cellular effects and lead to divergence of cagA-positive subclones.
Asunto(s)
Amoxicilina/farmacología , Antibacterianos/farmacología , Antígenos Bacterianos/efectos de los fármacos , Proteínas Bacterianas/efectos de los fármacos , Claritromicina/farmacología , Farmacorresistencia Bacteriana Múltiple/genética , Helicobacter pylori/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Adolescente , Adulto , Anciano , Antígenos Bacterianos/genética , Proteínas Bacterianas/genética , Distribución de Chi-Cuadrado , Colombia , Femenino , Reordenamiento Génico/efectos de los fármacos , Islas Genómicas/efectos de los fármacos , Islas Genómicas/genética , Helicobacter pylori/genética , Helicobacter pylori/aislamiento & purificación , Helicobacter pylori/patogenicidad , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Análisis Multivariante , Fosforilación , Estómago/microbiología , Tirosina/metabolismo , Virulencia/efectos de los fármacos , Virulencia/genética , Adulto JovenRESUMEN
In Arabidopsis (Arabidopsis thaliana), malate released into the rhizosphere has various roles, such as detoxifying rhizotoxic aluminum (Al) and recruiting beneficial rhizobacteria that induce plant immunity. ALUMINUM-ACTIVATED MALATE TRANSPORTER1 (AtALMT1) is a critical gene in these responses, but its regulatory mechanisms remain unclear. To explore the mechanism of the multiple responses of AtALMT1, we profiled its expression patterns in wild-type plants, in transgenic plants harboring various deleted promoter constructs, and in mutant plants with defects in signal transduction in response to various inducers. AtALMT1 transcription was clearly induced by indole-3-acetic acid (IAA), abscisic acid (ABA), low pH, and hydrogen peroxide, indicating that it was able to respond to multiple signals, while it was not induced by methyl jasmonate and salicylic acid. The IAA-signaling double mutant nonphototropic hypocotyls4-1; auxin-responsive factor19-1 and the ABA-signaling mutant aba insensitive1-1 did not respond to auxin and ABA, respectively, but both showed an Al response comparable to that of the wild type. A synthetic microbe-associated molecular pattern peptide, flagellin22 (flg22), induced AtALMT1 transcription but did not induce the transcription of IAA- and ABA-responsive biomarker genes, indicating that both Al and flg22 responses of AtALMT1 were independent of IAA and ABA signaling. An in planta ß-glucuronidase reporter assay identified that the ABA response was regulated by a region upstream (-317 bp) from the first ATG codon, but other stress responses may share critical regulatory element(s) located between -292 and -317 bp. These results illustrate the complex regulation of AtALMT1 expression during the adaptation to abiotic and biotic stresses.
Asunto(s)
Proteínas de Arabidopsis/genética , Arabidopsis/genética , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Transportadores de Anión Orgánico/genética , Reguladores del Crecimiento de las Plantas/farmacología , Transportadoras de Casetes de Unión a ATP/genética , Ácido Abscísico/metabolismo , Ácido Abscísico/farmacología , Acetatos/farmacología , Adaptación Fisiológica , Arabidopsis/efectos de los fármacos , Arabidopsis/metabolismo , Proteínas de Arabidopsis/metabolismo , Ciclopentanos/farmacología , Peróxido de Hidrógeno/farmacología , Ácidos Indolacéticos/metabolismo , Ácidos Indolacéticos/farmacología , Macrólidos/farmacología , Mutación , Transportadores de Anión Orgánico/metabolismo , Oxilipinas/farmacología , Reguladores del Crecimiento de las Plantas/metabolismo , Raíces de Plantas/genética , Raíces de Plantas/metabolismo , Plantas Modificadas Genéticamente , Regiones Promotoras Genéticas , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Ácido Salicílico/farmacología , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genéticaRESUMEN
The use of shRNAmir to down-regulate the expression of genes of interest is a powerful tool for studying gene function during early chick development. However, because of the limitations of electroporation-mediated transgenesis, the down-regulation of genes expressed at late stages of development in specific tissues is difficult to perform. By combining electroporation of a doxycycline-inducible, miR30-based shRNA plasmid with the Tol2 genomic integration system, we are now able to down-regulate the expression of any gene of interest at defined stage of chicken development.
Asunto(s)
Pollos/genética , Regulación del Desarrollo de la Expresión Génica , Animales , Embrión de Pollo , Pollos/metabolismo , Elementos Transponibles de ADN , Regulación hacia Abajo , Doxiciclina/farmacología , Electroporación , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Orden Génico , Vectores Genéticos/genética , MicroARNs/genética , Mutagénesis Insercional , Especificidad de Órganos/genética , Factor de Transcripción PAX7/genética , Factor de Transcripción PAX7/metabolismo , Interferencia de ARN , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacosRESUMEN
Members of the genus Acinetobacter have been the focus recent attention due to both their clinical significance and application to molecular biology. The soil commensal bacterium Acinetobacter baylyi ADP1 has been proposed as a model system for molecular and genetic studies, whereas in a clinical environment, Acinetobacter spp. are of increasing importance due to their propensity to cause serious and intractable systemic infections. Clinically, a major factor in the success of Acinetobacter spp. as opportunistic pathogens can be attributed to their ability to rapidly evolve resistance to common antimicrobial compounds. Whole genome sequencing of clinical and environmental Acinetobacter spp. isolates has revealed the presence of numerous multidrug transporters within the core and accessory genomes, suggesting that efflux is an important host defense response in this genus. In this work, we used the drug-susceptible organism A. baylyi ADP1 as a model for studies into the evolution of efflux mediated resistance in genus Acinetobacter, due to the high level of conservation of efflux determinants across four diverse Acinetobacter strains, including clinical isolates. A single exposure of therapeutic concentrations of chloramphenicol to populations of A. baylyi ADP1 cells produced five individual colonies displaying multidrug resistance. The major facilitator superfamily pump craA was upregulated in one mutant strain, whereas the resistance nodulation division pump adeJ was upregulated in the remaining four. Within the adeJ upregulated population, two different levels of adeJ mRNA transcription were observed, suggesting at least three separate mutations were selected after single-step exposure to chloramphenicol. In the craA upregulated strain, a T to G substitution 12 nt upstream of the craA translation initiation codon was observed. Subsequent mRNA stability analyses using this strain revealed that the half-life of mutant craA mRNA was significantly greater than that of wild-type craA mRNA.
Asunto(s)
Acinetobacter/efectos de los fármacos , Acinetobacter/genética , Evolución Molecular Dirigida/métodos , Farmacorresistencia Bacteriana/genética , Resistencia a Múltiples Medicamentos/genética , Mutación , Acinetobacter/fisiología , Cloranfenicol/farmacología , Secuencia Conservada , Resistencia a Múltiples Medicamentos/efectos de los fármacos , Eliminación de Gen , Genes Bacterianos/genética , Genes MDR/genética , Humanos , Estabilidad del ARN/efectos de los fármacos , ARN Mensajero/química , ARN Mensajero/genética , ARN Mensajero/metabolismo , Recombinación Genética/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/genética , Transcripción Genética/efectos de los fármacos , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/genéticaRESUMEN
Expression divergence is thought to be a hallmark of functional diversification between homologs post duplication. Modification in regulatory elements has been invoked to explain expression divergence after duplication for several MADS-box genes, however, verification of reciprocal loss of cis-regulatory elements is lacking in plants. Here, we report that the evolution of MPF2-like genes has entailed degenerative mutations in a core promoter CArG-box and an auxin response factor (ARF) binding element in the large 1(st) intron in the coding region. Previously, MPF2-like genes were duplicated into MPF2-like-A and -B through genome duplication in Withania and Tubocapsicum (Withaninae). The calyx of Withania grows exorbitantly after pollination unlike Tubocapsicum, where it degenerates. Besides inflated calyx syndrome formation, MPF2-like transcription factors are implicated in functions both during the vegetative and reproductive development as well as in phase transition. MPF2-like-A of Withania (WSA206) is strongly expressed in sepals, while MPF2-like-B (WSB206) is not. Interestingly, their combined expression patterns seem to replicate the pattern of their closely related hypothetical progenitors from Vassobia and Physalis. Using phylogenetic shadowing, site-directed mutagenesis and motif swapping, we could show that the loss of a conserved CArG-box in MPF2-like-B of Withania is responsible for impeding its expression in sepals. Conversely, loss of an ARE in MPF2-like-A relaxed the constraint on expression in sepals. Thus, the ARE is an active suppressor of MPF2-like gene expression in sepals, which in contrast is activated via the CArG-box. The observed expression divergence in MPF2-like genes due to reciprocal loss of cis-regulatory elements has added to genetic and phenotypic variations in the Withaninae and enhanced the potential of natural selection for the adaptive evolution of ICS. Moreover, these results provide insight into the interplay of floral developmental and hormonal pathways during ICS development and add to the understanding of the importance of polyploidy in plants.
Asunto(s)
Flores/genética , Eliminación de Gen , Ácidos Indolacéticos , Proteínas de Dominio MADS/genética , Reguladores del Crecimiento de las Plantas , Secuencias Reguladoras de Ácidos Nucleicos , Elementos de Respuesta , Factores de Ribosilacion-ADP/metabolismo , Arabidopsis/genética , Secuencia de Bases , Sitios de Unión/genética , Biología Computacional/métodos , Flores/anatomía & histología , Flores/crecimiento & desarrollo , Duplicación de Gen , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Orden Génico , Genes de Plantas , Genes Reporteros , Ácidos Indolacéticos/farmacología , Intrones , Datos de Secuencia Molecular , Fenotipo , Filogenia , Células Vegetales , Reguladores del Crecimiento de las Plantas/farmacología , Plantas Modificadas Genéticamente , Polinización , Regiones Promotoras Genéticas , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Elementos de Respuesta/efectos de los fármacos , Alineación de Secuencia , Withania/clasificación , Withania/genéticaRESUMEN
Epigenetic 5-azacitidine (AZA) therapy of high-risk myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) represents a promising, albeit not fully understood, approach. Hematopoietic transcription factor PU.1 is dynamically regulated by upstream regulatory element (URE), whose deletion causes downregulation of PU.1 leading to AML in mouse. In this study a significant group of the high-risk MDS patients, as well as MDS cell lines, displayed downregulation of PU.1 expression within CD34+ cells, which was associated with DNA methylation of the URE. AZA treatment in vitro significantly demethylated URE, leading to upregulation of PU.1 followed by derepression of its transcriptional targets and onset of myeloid differentiation. Addition of colony-stimulating factors (CSFs; granulocyte-CSF, granulocyte-macrophage-CSF and macrophage-CSF) modulated AZA-mediated effects on reprogramming of histone modifications at the URE and cell differentiation outcome. Our data collectively support the importance of modifying the URE chromatin structure as a regulatory mechanism of AZA-mediated activation of PU.1 and induction of the myeloid program in MDS.
Asunto(s)
Antimetabolitos Antineoplásicos/uso terapéutico , Azacitidina/uso terapéutico , Cromatina/genética , Síndromes Mielodisplásicos/tratamiento farmacológico , Síndromes Mielodisplásicos/genética , Proteínas Proto-Oncogénicas/genética , Transactivadores/genética , Anciano , Anciano de 80 o más Años , Antimetabolitos Antineoplásicos/farmacología , Azacitidina/farmacología , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/genética , Línea Celular Tumoral , Factores Estimulantes de Colonias/farmacología , Metilación de ADN/efectos de los fármacos , Femenino , Regulación Leucémica de la Expresión Génica/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Células Madre Neoplásicas/citología , Células Madre Neoplásicas/efectos de los fármacos , Células Madre Neoplásicas/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Transactivadores/metabolismo , Activación Transcripcional/efectos de los fármacosRESUMEN
Recruitment of Oct-1 protein to the octamer sequence of U6 promoter is critical for optimal transcription by RNA polymerase III. Here we report that p38 kinase inhibitors, SB202190 and SB203580, stimulated U6 promoter activity and this stimulation can be observed only in the presence of octamer sequence. SB202190-treated cell nuclear extract had about 50% increase in Oct-1 binding activity suggesting that the increased U6 promoter activity by p38 kinase inhibitor is mediated through Oct-1. Mutation in octamer sequence significantly reduced the SB202190-stimulated U6 promoter transcription and the distance between octamer and proximal sequence element of U6 promoter is also critical for the p38 kinase inhibitor-stimulated activity. Exogenous Oct-1 expression showed a concentration-dependent activation of U6 promoter that was further stimulated by the p38 kinase inhibitors. When cells were treated with p38 kinase inducer, hydrogen peroxide or phorbol 12-myristate 13-acetate (PMA), U6 promoter activity was down regulated and this inhibition was reversed by p38 kinase inhibitors. Over-expression of p38α kinase down-regulated U6 promoter activity and this inhibition was further enhanced by PMA and p38 kinase inhibitors reversed this inhibition. p38 kinase inhibitor-treated cells had 50% more U6 RNA than the control cells. Taken together, our results show a negative correlation between the p38 kinase levels and Oct-1 binding on U6 promoter, suggesting that U6 promoter is negatively regulated by p38 kinase.
Asunto(s)
Proteínas de Unión al ADN/genética , Regulación hacia Abajo/genética , Factor 1 de Transcripción de Unión a Octámeros/genética , ARN Nuclear Pequeño/genética , Proteínas Quinasas p38 Activadas por Mitógenos/genética , Proteínas de Unión al ADN/metabolismo , Humanos , Imidazoles/farmacología , Células Jurkat , Mutación , Factor 1 de Transcripción de Unión a Octámeros/metabolismo , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/genética , Regiones Promotoras Genéticas , Piridinas/farmacología , ARN Nuclear Pequeño/metabolismo , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Transcripción Genética/efectos de los fármacos , Células Tumorales Cultivadas , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismoRESUMEN
Oct4 is a POU domain homeobox gene, expressed in undifferentiated embryonal carcinoma and embryonic stem cells and is quickly down-regulated upon induction of differentiation. Transcriptional repression of Oct4 is followed by pronounced epigenetic changes on the regulatory region of the gene. Oct4 has a long upstream regulatory region of about 2,600 bp, consisting of proximal enhancer (PE), distal enhancer (DE), and proximal promoter (PP). In this study, we induced differentiation of a human embryonic carcinoma cell line, NT2, under two different adherent and non-adherent culture conditions, and compared histone modifications as the epigenetic marks on the regulatory region of Oct4 gene after 3 days of differentiation. Using chromatin immunoprecipitation coupled with real-time PCR technique, it was shown that the after induction of differentiation the repressive epigenetic marks of hypoacetylation and methylation on lysine-9 of histone H3 occurred very effectively on the upstream of Oct4, especially in PP region. Also, comparing the two culturing systems it was shown that methylation of lysine-9 of H3 histone was more drastic in PE region of adherent cells rather than suspension cells. This epigenetic profile was in agreement with the difference observed in the expression level of Oct4 in these two culturing systems. The current study clearly shows the effective role of cell culture condition on the epigenetic regulation of gene expression.
Asunto(s)
Carcinoma Embrionario/genética , Adhesión Celular , Diferenciación Celular/efectos de los fármacos , Epigénesis Genética/efectos de los fármacos , Histonas/metabolismo , Factor 3 de Transcripción de Unión a Octámeros/genética , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Tretinoina/farmacología , Acetilación , Carcinoma Embrionario/metabolismo , Carcinoma Embrionario/patología , Técnicas de Cultivo de Célula , Línea Celular Tumoral , Inmunoprecipitación de Cromatina , Regulación hacia Abajo , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Lisina , Metilación , Factor 3 de Transcripción de Unión a Octámeros/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa , Factores de TiempoRESUMEN
Genetic variants altering cis-regulation of normal gene expression (cis-eQTLs) have been extensively mapped in human cells and tissues, but the extent by which controlled, environmental perturbation influences cis-eQTLs is unclear. We carried out large-scale induction experiments using primary human bone cells derived from unrelated donors of Swedish origin treated with 18 different stimuli (7 treatments and 2 controls, each assessed at 2 time points). The treatments with the largest impact on the transcriptome, verified on two independent expression arrays, included BMP-2 (tâ=â2h), dexamethasone (DEX) (tâ=â24 h), and PGE2 (tâ=â24 h). Using these treatments and control, we performed expression profiling for 18,144 RefSeq transcripts on biological replicates of the complete study cohort of 113 individuals (n(total)â=â782) and combined it with genome-wide SNP-genotyping data in order to map treatment-specific cis-eQTLs (defined as SNPs located within the gene ± 250 kb). We found that 93% of cis-eQTLs at 1% FDR were observed in at least one additional treatment, and in fact, on average, only 1.4% of the cis-eQTLs were considered as treatment-specific at high confidence. The relative invariability of cis-regulation following perturbation was reiterated independently by genome-wide allelic expression tests where only a small proportion of variance could be attributed to treatment. Treatment-specific cis-regulatory effects were, however, 2- to 6-fold more abundant among differently expressed genes upon treatment. We further followed-up and validated the DEX-specific cis-regulation of the MYO6 and TNC loci and found top cis-regulatory variants located 180 kb and 250 kb upstream of the transcription start sites, respectively. Our results suggest that, as opposed to tissue-specificity of cis-eQTLs, the interactions between cellular environment and cis-variants are relatively rare (â¼1.5%), but that detection of such specific interactions can be achieved by a combination of functional genomic approaches as described here.
Asunto(s)
Exposición a Riesgos Ambientales , Regulación de la Expresión Génica , Osteoblastos/metabolismo , Secuencias Reguladoras de Ácidos Nucleicos/genética , Proteína Morfogenética Ósea 2/farmacología , Dexametasona/farmacología , Dinoprostona/farmacología , Femenino , Perfilación de la Expresión Génica , Regulación de la Expresión Génica/efectos de los fármacos , Redes Reguladoras de Genes , Marcadores Genéticos , Genotipo , Humanos , Masculino , Especificidad de Órganos/genética , Osteoblastos/efectos de los fármacos , Polimorfismo de Nucleótido Simple/genética , Sitios de Carácter Cuantitativo , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacosRESUMEN
The study was designed to elucidate the influence of the protein kinase A (PKA) signal transduction pathway on transcription of the LIPE gene encoding hormone-sensitive lipase/cholesteryl esterase (HSL) in H295R cells. HSL is one of the key enzymes involved in steroid hormone synthesis, and ACTH, with mediation of the PKA pathway, increases its activity. However, the mode of regulation of LIPE gene expression by ACTH remains unknown. It was found that stimulation of the PKA pathway by the adenylyl cyclase activator, forskolin, caused a twofold increase in LIPE transcript accompanied by appreciable rise in the protein product of the gene and cortisol output. RNA polymerase II inhibitor abolished, and protein synthesis inhibitor attenuated this effect. Forskolin and PKA catalytic subunit increased transcriptional activity of LIPE promoter A in cells transfected with the luciferase reporter vector. Overexpression of steroidogenic factor-1 (SF-1) increased LIPE promoter activity, while transient silencing of SF-1 expression with specific siRNAs abolished forskolin-stimulated LIPE transcription. It is concluded that ACTH via the PKA pathway stimulates expression of SF-1, which activates transcription of LIPE presumably by interaction with putative binding sequences within promoter A. A novel mechanism contributing to the long-term effect of ACTH on adrenal steroidogenesis is proposed: ACTH stimulates transcription of SF-1, which interacts with the putative SF-1-binding sequences within the promoter and activates LIPE transcription. An increased level of HSL results in an enhanced supply of cholesterol required for steroid hormone synthesis.
Asunto(s)
Corteza Suprarrenal/metabolismo , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Factor Esteroidogénico 1/metabolismo , Esterol Esterasa/genética , Transcripción Genética , Hormona Adrenocorticotrópica/genética , Hormona Adrenocorticotrópica/metabolismo , Secuencia de Bases , Línea Celular , Colesterol/biosíntesis , Colforsina/farmacología , Proteínas Quinasas Dependientes de AMP Cíclico/genética , Expresión Génica , Regulación de la Expresión Génica , Humanos , Hidrocortisona/metabolismo , Luciferasas , Regiones Promotoras Genéticas , Inhibidores de la Síntesis de la Proteína/farmacología , Interferencia de ARN , ARN Polimerasa II/antagonistas & inhibidores , ARN Interferente Pequeño/genética , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal/efectos de los fármacos , Factor Esteroidogénico 1/genética , Esterol Esterasa/biosíntesis , Esterol Esterasa/metabolismoRESUMEN
We determined rates of resistance to the ketolide telithromycin in 56 Enterococcus faecalis isolates and 44 Enterococcus faecium isolates collected from hospitals in Korea between 2005 and 2006. Twenty nine (51.8%) isolates of E. faecalis and 35 (79.5%) isolates of E. faecium were resistant to telithromycin (minimum inhibitory concentrations, ≥ 4 µg/mL). All of the telithromycin-resistant E. faecalis carried the erm(B) gene only. Of the telithromycin-resistant E. faecium, 29 resistant strains carried erm(B) only, the other six carried erm(A) and erm(B) together. The nucleotide sequence of the erm(B) regulatory regions from 29 E. faecalis and 29 E. faecium isolates with erm(B) only was analyzed. Five types of alterations were detected. The first and second types had point mutations that destabilize the secondary structure of erm(B) mRNA sequestering the translation initiation region of the structural gene. The third type was identical to erm(Bv1), a previously reported variant of erm(B) with different induction specificity. The fourth and fifth types had point mutations within the critical sequence for induction and a point mutation destabilizing the stem-loop of erm(B) mRNA sequestering the translation initiation region of the structural gene.